BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)
 4,670.00
 +70.00 (1.52%)
  Oct 31, 2025, 3:30 PM KST
BCWORLD PHARM. Revenue
BCWORLD PHARM. had revenue of 20.44B KRW in the quarter ending June 30, 2025, with 5.05% growth. This brings the company's revenue in the last twelve months to 75.32B, up 3.23% year-over-year. In the year 2024, BCWORLD PHARM. had annual revenue of 74.81B, down -0.39%.
Revenue (ttm) 
 75.32B
Revenue Growth 
 +3.23%
P/S Ratio 
 0.52
Revenue / Employee 
 268.99M
Employees 
 280
Market Cap 
38.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 74.81B | -296.36M | -0.39% | 
| Dec 31, 2023 | 75.11B | 2.41B | 3.31% | 
| Dec 31, 2022 | 72.70B | 10.62B | 17.11% | 
| Dec 31, 2021 | 62.08B | 5.05B | 8.85% | 
| Dec 31, 2020 | 57.03B | 5.53B | 10.74% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Samsung Biologics | 5.03T | 
| Celltrion | 3.75T | 
| Yuhan | 2.17T | 
| SK Biopharmaceuticals | 620.28B | 
| PharmaResearch | 449.81B | 
| Sam Chun Dang Pharm. | 215.10B | 
| ALTEOGEN | 158.06B | 
| LigaChem Biosciences | 148.28B |